Life Sciences Innovative Manufacturing Fund (LSIMF): Expression of Interest
Capital grants to support investments over £8m in the manufacture of human medicines, medical diagnostics and medtech products; assessed quarterly
Opportunity Details
LSIMF accepts EOIs on a rolling basis. Applications will be assessed in quarterly rounds until all funding has been allocated.
Award
Your project must ave a total cost (capital and non-capital costs) of at least £8m. You must only apply for the amount you require to proceed with the investment.
Organisation
DSIT
The government has committed up to £520 million for life sciences manufacturing, to help deliver on the government’s missions to kickstart economic growth and build an NHS fit for the future.
The LSIMF will be UK and sector wide and will provide capital grants for investments in the manufacture of:
- Human medicines (this includes both the manufacture of active pharmaceutical ingredients (API) / drug substance and finished product / drug product).
- Medical diagnostics – for both disease identification and monitoring.
- MedTech products – all types of medical devices related to human health.
The fund is open to applications for MHRA-licenced medicines, medical and diagnostic devices registered with the MHRA, and products in development where approval to market the device in the UK is intended to be sought for commercial scale-up, for example a manufacturing project for clinical trials or investigational studies.
Who can apply
To be eligible for the fund, your company must be a:
- UK registered company.
- Wholly private sector business.
- Product developer, contract development manufacturing organisation, or a generics manufacturer.
Applicants will be prioritised based on their alignment to the fund’s objectives:
- To increase UK health resilience by strengthening the UK’s manufacturing capacity and capability. We define health resilience as the UK’s ability to withstand and recover from health emergencies such as pandemics, long-term healthcare challenges and system shocks such as supply chain disruption.
- To create economic opportunity through investments that will make a substantial contribution to Gross Value Added (GVA) and provide high-wage, high-skilled jobs around the UK.
Eligible projects
To be eligible for the fund, your project must:
- Have a total cost (capital and non-capital costs) of at least £8 million
- Be located in the UK
- Be primarily a capital investment
- Be a single company investment (as opposed to forming a partnership between companies or other types of organisations)
- Require only the amount of grant requested to proceed. For example, without the specific amount of funding you are requesting your project wouldn’t go ahead or go ahead at a smaller scale, go ahead overseas or would be significantly delayed (3 years or more)
- Be a manufacturing project for the manufacture of:
- Human medicines (this includes both the manufacture of active pharmaceutical ingredients (API) / drug substance and finished product / drug product).
- Medical diagnostics – for both disease identification and monitoring
- MedTech products – all types of medical devices related to human health.
If you have any queries about eligibility, you can contact Innovate UK Business Connect’s Health team.
How to apply
Submit your EOI at the link below. Your EOI will be used to assess your project’s eligibility and can be submitted at any time whilst the fund is open. If your project is deemed eligible, you will be invited to submit an application.